Dispatch of Annual Report and Shareholder Circular

RNS Number : 7186V

Physiomics PLC

09 November 2017

 

9^th November 2017          

Physiomics plc

("Physiomics") or ("the Company")

Dispatch of Annual Report and Shareholder Circular

Dispatch of Documentation

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has published and posted to shareholders

-    its Annual Report for the financial year ended 30^th June 2017 and

-    a circular in relation to its forthcoming Annual General Meeting

As already announced on the 16^th October 2017, the Company's Annual General Meeting will be held at 10:00 a.m. on 13^th December 2017 at the Company's registered office, The Magdalen Centre, Oxford Science Park, Robert Robinson Avenue, Oxford, OX4 4GA.

Resolutions To Be Proposed At The Annual General Meeting

Ordinary Resolutions:

1. To receive and adopt the financial statements and the report of the directors and auditors of the Company for the period ended 30 June 2017.

2. To re-appoint Dr Jim Millen as a Director of the Company

3. To confirm the appointment of Shipleys LLP as auditors of the Company to hold office until the conclusion of the next Annual General Meeting at which annual accounts of the Company are laid and to authorise the Directors to fix their remuneration

4. To authorise the directors to allot shares pursuant to section 551 of the Companies Act 2006.

Special Resolution

5. To disapply section 561 of the Companies Act 2006 in relation to the allotment in resolution (4) above.

EXPECTED TIMETABLE OF EVENTS

Latest time for receipt of Forms of Proxy:	10 a.m. on 11th December 2017
Annual General Meeting:	10 a.m. on 13th December 2017

ADDITIONAL STATISTICS

Number of Existing Ordinary Shares of 0.4p in issue at the date of this document

57,016,579

A copy of the Circular containing further details of the resolutions as well as a copy of the Company's Annual Report will be made available on the Company's website.

Enquiries:

Physiomics plc                                                  

Dr Jim Millen, CEO

[phone]

WH Ireland Limited (nomad)

Katy Mitchell

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

 

END

 

 

MSCLLFLALILRIID